Jounce Therapeutics Inc (JNCE) Gross Profit Margin starting from the fourth quarter 2022 to fourth quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Jounce Therapeutics inc   (NASDAQ: JNCE)


Jounce Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



JNCE Gross Profit Margin (Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $82.00
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 1182
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2022 Gross Profit Margin



Observing fourth quarter 2022 results within Biotechnology & Pharmaceuticals industry 62 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
JNCE's Gross Profit Margin fourth quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 63
Healthcare Sector # 264
Overall # 1182

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Dec 31 2022)  




Other Gross Profit Margin Profitability Ratios
JNCE's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
JNCE's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for JNCE's Competitors
Gross Profit Margin Profit Margin for Jounce Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for JNCE's Customers

You may also want to know
JNCE's Annual Growth Rates JNCE's Profitability Ratios JNCE's Asset Turnover Ratio JNCE's Dividend Growth
JNCE's Roe JNCE's Valuation Ratios JNCE's Financial Strength Ratios JNCE's Gross Profit Growth
JNCE's Roa JNCE's Inventory Turnover Ratio JNCE's Growth Rates JNCE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.